Shopping Cart 0
Cart Subtotal
USD 0

Interbody Cages - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500

Details

Interbody Cages-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Interbody Cages-Medical Devices Pipeline Assessment, 2018" provides an overview of Interbody Cages currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interbody Cages pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Interbody Cages under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Interbody Cages and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Interbody Cages under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Interbody Cages Overview 6

3 Products under Development 7

3.1 Interbody Cages-Pipeline Products by Stage of Development 7

3.2 Interbody Cages-Pipeline Products by Territory 8

3.3 Interbody Cages-Pipeline Products by Regulatory Path 9

3.4 Interbody Cages-Pipeline Products by Estimated Approval Date 10

4 Interbody Cages-Pipeline Products under Development by Companies 11

4.1 Interbody Cages Companies-Pipeline Products by Stage of Development 11

4.2 Interbody Cages-Pipeline Products by Stage of Development 12

5 Interbody Cages Companies and Product Overview 13

5.1 Camber Spine Technologies LLC Company Overview 13

5.1.1 Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Corelink, LLC Company Overview 16

5.2.1 Corelink, LLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 DePuy Synthes Inc Company Overview 18

5.3.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 EIT Emerging Implant Technologies GmbH Company Overview 19

5.4.1 EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Inion Oy Company Overview 21

5.5.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 KISCO International Company Overview 23

5.6.1 KISCO International Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 Maxigen Biotech Inc Company Overview 24

5.7.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Medyssey Co Ltd Company Overview 25

5.8.1 Medyssey Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

5.9 Safe Orthopaedics SA Company Overview 26

5.9.1 Safe Orthopaedics SA Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Spinal Balance Inc. Company Overview 29

5.10.1 Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 University of South Florida Company Overview 30

5.11.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 Vivonics, Inc. Company Overview 31

5.12.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

6 Interbody Cages- Recent Developments 32

6.1 Apr 11, 2018: CoreLink Announces Full Commercial Launch of Foundation 3D Printed Titanium Interbody Cage Systems 32

6.2 Mar 15, 2018: Stryker Spine Division's Tritanium C Anterior Cervical Cage Gains Momentum With Surgeons 32

6.3 Dec 20, 2017: K2M Introduces World's First 3D-Printed Expandable Corpectomy Cage With Cervical Spine Indications Following CE Mark of CAPRI Cervical 3D Expandable Featuring Lamellar 3D Titanium Technology 33

6.4 Dec 07, 2017: Camber Spine Announces FDA Clearance Of Spira-C Open Matrix Cervical Interbody 34

6.5 Dec 04, 2017: Dr. Adam Lewis to Adopt EOI's FLXfit Articulated and Expandable Cages as His Treatment of Choice for MIS TLIF 35

6.6 Oct 26, 2017: EOI Announces Initial Surgeries With the FLXfit 15, the First Articulated and Expandable Cage With 15 Degrees of Lordosis Correction 35

6.7 Oct 23, 2017: Strykers Spine Division to Launch Tritanium C Anterior Cervical Cage at NASS 2017 36

6.8 Oct 09, 2017: Stryker's 3D-Printed Tritanium C Anterior Cervical Cage to be Featured at Congress of Neurological Surgeons Meeting 36

6.9 Sep 28, 2017: EOI Announces FDA Clearance for the FLXfit15, the Only 3D Articulated Expandable Cage With 15 degrees of Lordosis Correction 37

6.10 Sep 20, 2017: Stryker's Spine Division Receives FDA Clearance for 3D-Printed Tritanium C Anterior Cervical Cage 38

6.11 Jul 25, 2017: Dr. Skidmore Reports Promising Results on a 30 Patients' Series with EOI's 3D Expandable FLXfit Cage 38

7 Appendix 39

7.1 Methodology 39

7.2 About GlobalData 42

7.3 Contact Us 42

7.4 Disclaimer 42


List Of Figure

1.2 List of Figures

Figure 1: Interbody Cages-Pipeline Products by Stage of Development 7

Figure 2: Interbody Cages-Pipeline Products by Territory 8

Figure 3: Interbody Cages-Pipeline Products by Regulatory Path 9

Figure 4: Interbody Cages-Pipeline Products by Estimated Approval Date 10


List Of Table

1.1 List of Tables

Table 1: Interbody Cages-Pipeline Products by Stage of Development 7

Table 2: Interbody Cages-Pipeline Products by Territory 8

Table 3: Interbody Cages-Pipeline Products by Regulatory Path 9

Table 4: Interbody Cages-Pipeline Products by Estimated Approval Date 10

Table 5: Interbody Cages Companies-Pipeline Products by Stage of Development 11

Table 6: Interbody Cages-Pipeline Products by Stage of Development 12

Table 7: Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 13

Table 8: SPIRA Lateral-Product Status 13

Table 9: SPIRA Lateral-Product Description 13

Table 10: SPIRA Posterior Lumbar-Product Status 14

Table 11: SPIRA Posterior Lumbar-Product Description 14

Table 12: SPIRA-L Open Architecture Lateral Cage-Product Status 14

Table 13: SPIRA-L Open Architecture Lateral Cage-Product Description 15

Table 14: Corelink, LLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 15: Stand Alone Cervical Cage System-Product Status 16

Table 16: Stand Alone Cervical Cage System-Product Description 16

Table 17: Stand Alone Lumbar Cage System-Product Status 17

Table 18: Stand Alone Lumbar Cage System-Product Description 17

Table 19: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 20: Expandable Cage-Spine-Product Status 18

Table 21: Expandable Cage-Spine-Product Description 18

Table 22: EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 19

Table 23: Fully Printed Lateral Expanding Cage-Product Status 19

Table 24: Fully Printed Lateral Expanding Cage-Product Description 19

Table 25: Lateral Lumbar Cage-Product Status 20

Table 26: Lateral Lumbar Cage-Product Description 20

Table 27: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 21

Table 28: Cervical Cage-Product Status 21

Table 29: Cervical Cage-Product Description 21

Table 30: Lumbar Cage-Product Status 22

Table 31: Lumbar Cage-Product Description 22

Table 32: KISCO International Pipeline Products & Ongoing Clinical Trials Overview 23

Table 33: Cambo-Product Status 23

Table 34: Cambo-Product Description 23

Table 35: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 36: MaxiCage-Product Status 24

Table 37: MaxiCage-Product Description 24

Table 38: Medyssey Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

Table 39: Unicorn Cs-Product Status 25

Table 40: Unicorn Cs-Product Description 25

Table 41: Safe Orthopaedics SA Pipeline Products & Ongoing Clinical Trials Overview 26

Table 42: Cedar-Product Status 26

Table 43: Cedar-Product Description 27

Table 44: Elm-Product Status 27

Table 45: Elm-Product Description 27

Table 46: Walnut-Product Status 28

Table 47: Walnut-Product Description 28

Table 48: Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Table 49: Interbody Cage-Product Status 29

Table 50: Interbody Cage-Product Description 29

Table 51: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 30

Table 52: Vertebral Body Cage-Product Status 30

Table 53: Vertebral Body Cage-Product Description 30

Table 54: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 55: MIDIS Cage-Product Status 31

Table 56: MIDIS Cage-Product Description 31

Table 57: Glossary 41

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Camber Spine Technologies LLC, SPIRA Lateral; Camber Spine Technologies LLC, SPIRA Posterior Lumbar; Camber Spine Technologies LLC, SPIRA-L Open Architecture Lateral Cage; Corelink, LLC, Stand Alone Cervical Cage System; Corelink, LLC, Stand Alone Lumbar Cage System; DePuy Synthes Inc, Expandable Cage - Spine; EIT Emerging Implant Technologies GmbH, Fully Printed Lateral Expanding Cage; EIT Emerging Implant Technologies GmbH, Lateral Lumbar Cage; Inion Oy, Cervical Cage; Inion Oy, Lumbar Cage; KISCO International, Cambo; Maxigen Biotech Inc, MaxiCage; Medyssey Co Ltd, Unicorn Cs; Safe Orthopaedics SA, Cedar; Safe Orthopaedics SA, Elm; Safe Orthopaedics SA, Walnut; Spinal Balance Inc. , Interbody Cage; University of South Florida, Vertebral Body Cage; Vivonics, Inc., MIDIS Cage


Companies

Camber Spine Technologies LLC

Corelink, LLC

DePuy Synthes Inc

EIT Emerging Implant Technologies GmbH

Inion Oy

KISCO International

Maxigen Biotech Inc

Medyssey Co Ltd

Safe Orthopaedics SA

Spinal Balance Inc.

University of South Florida

Vivonics, Inc.

Company Profile

Company Profile Title

Interbody Cages-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Interbody Cages-Medical Devices Pipeline Assessment, 2018" provides an overview of Interbody Cages currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interbody Cages pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Interbody Cages under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Interbody Cages and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Interbody Cages under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Interbody Cages Overview 6

3 Products under Development 7

3.1 Interbody Cages-Pipeline Products by Stage of Development 7

3.2 Interbody Cages-Pipeline Products by Territory 8

3.3 Interbody Cages-Pipeline Products by Regulatory Path 9

3.4 Interbody Cages-Pipeline Products by Estimated Approval Date 10

4 Interbody Cages-Pipeline Products under Development by Companies 11

4.1 Interbody Cages Companies-Pipeline Products by Stage of Development 11

4.2 Interbody Cages-Pipeline Products by Stage of Development 12

5 Interbody Cages Companies and Product Overview 13

5.1 Camber Spine Technologies LLC Company Overview 13

5.1.1 Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Corelink, LLC Company Overview 16

5.2.1 Corelink, LLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 DePuy Synthes Inc Company Overview 18

5.3.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 EIT Emerging Implant Technologies GmbH Company Overview 19

5.4.1 EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Inion Oy Company Overview 21

5.5.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 KISCO International Company Overview 23

5.6.1 KISCO International Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 Maxigen Biotech Inc Company Overview 24

5.7.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Medyssey Co Ltd Company Overview 25

5.8.1 Medyssey Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

5.9 Safe Orthopaedics SA Company Overview 26

5.9.1 Safe Orthopaedics SA Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Spinal Balance Inc. Company Overview 29

5.10.1 Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 University of South Florida Company Overview 30

5.11.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 Vivonics, Inc. Company Overview 31

5.12.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

6 Interbody Cages- Recent Developments 32

6.1 Apr 11, 2018: CoreLink Announces Full Commercial Launch of Foundation 3D Printed Titanium Interbody Cage Systems 32

6.2 Mar 15, 2018: Stryker Spine Division's Tritanium C Anterior Cervical Cage Gains Momentum With Surgeons 32

6.3 Dec 20, 2017: K2M Introduces World's First 3D-Printed Expandable Corpectomy Cage With Cervical Spine Indications Following CE Mark of CAPRI Cervical 3D Expandable Featuring Lamellar 3D Titanium Technology 33

6.4 Dec 07, 2017: Camber Spine Announces FDA Clearance Of Spira-C Open Matrix Cervical Interbody 34

6.5 Dec 04, 2017: Dr. Adam Lewis to Adopt EOI's FLXfit Articulated and Expandable Cages as His Treatment of Choice for MIS TLIF 35

6.6 Oct 26, 2017: EOI Announces Initial Surgeries With the FLXfit 15, the First Articulated and Expandable Cage With 15 Degrees of Lordosis Correction 35

6.7 Oct 23, 2017: Strykers Spine Division to Launch Tritanium C Anterior Cervical Cage at NASS 2017 36

6.8 Oct 09, 2017: Stryker's 3D-Printed Tritanium C Anterior Cervical Cage to be Featured at Congress of Neurological Surgeons Meeting 36

6.9 Sep 28, 2017: EOI Announces FDA Clearance for the FLXfit15, the Only 3D Articulated Expandable Cage With 15 degrees of Lordosis Correction 37

6.10 Sep 20, 2017: Stryker's Spine Division Receives FDA Clearance for 3D-Printed Tritanium C Anterior Cervical Cage 38

6.11 Jul 25, 2017: Dr. Skidmore Reports Promising Results on a 30 Patients' Series with EOI's 3D Expandable FLXfit Cage 38

7 Appendix 39

7.1 Methodology 39

7.2 About GlobalData 42

7.3 Contact Us 42

7.4 Disclaimer 42


List Of Figure

1.2 List of Figures

Figure 1: Interbody Cages-Pipeline Products by Stage of Development 7

Figure 2: Interbody Cages-Pipeline Products by Territory 8

Figure 3: Interbody Cages-Pipeline Products by Regulatory Path 9

Figure 4: Interbody Cages-Pipeline Products by Estimated Approval Date 10


List Of Table

1.1 List of Tables

Table 1: Interbody Cages-Pipeline Products by Stage of Development 7

Table 2: Interbody Cages-Pipeline Products by Territory 8

Table 3: Interbody Cages-Pipeline Products by Regulatory Path 9

Table 4: Interbody Cages-Pipeline Products by Estimated Approval Date 10

Table 5: Interbody Cages Companies-Pipeline Products by Stage of Development 11

Table 6: Interbody Cages-Pipeline Products by Stage of Development 12

Table 7: Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 13

Table 8: SPIRA Lateral-Product Status 13

Table 9: SPIRA Lateral-Product Description 13

Table 10: SPIRA Posterior Lumbar-Product Status 14

Table 11: SPIRA Posterior Lumbar-Product Description 14

Table 12: SPIRA-L Open Architecture Lateral Cage-Product Status 14

Table 13: SPIRA-L Open Architecture Lateral Cage-Product Description 15

Table 14: Corelink, LLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 15: Stand Alone Cervical Cage System-Product Status 16

Table 16: Stand Alone Cervical Cage System-Product Description 16

Table 17: Stand Alone Lumbar Cage System-Product Status 17

Table 18: Stand Alone Lumbar Cage System-Product Description 17

Table 19: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 20: Expandable Cage-Spine-Product Status 18

Table 21: Expandable Cage-Spine-Product Description 18

Table 22: EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 19

Table 23: Fully Printed Lateral Expanding Cage-Product Status 19

Table 24: Fully Printed Lateral Expanding Cage-Product Description 19

Table 25: Lateral Lumbar Cage-Product Status 20

Table 26: Lateral Lumbar Cage-Product Description 20

Table 27: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 21

Table 28: Cervical Cage-Product Status 21

Table 29: Cervical Cage-Product Description 21

Table 30: Lumbar Cage-Product Status 22

Table 31: Lumbar Cage-Product Description 22

Table 32: KISCO International Pipeline Products & Ongoing Clinical Trials Overview 23

Table 33: Cambo-Product Status 23

Table 34: Cambo-Product Description 23

Table 35: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 36: MaxiCage-Product Status 24

Table 37: MaxiCage-Product Description 24

Table 38: Medyssey Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

Table 39: Unicorn Cs-Product Status 25

Table 40: Unicorn Cs-Product Description 25

Table 41: Safe Orthopaedics SA Pipeline Products & Ongoing Clinical Trials Overview 26

Table 42: Cedar-Product Status 26

Table 43: Cedar-Product Description 27

Table 44: Elm-Product Status 27

Table 45: Elm-Product Description 27

Table 46: Walnut-Product Status 28

Table 47: Walnut-Product Description 28

Table 48: Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Table 49: Interbody Cage-Product Status 29

Table 50: Interbody Cage-Product Description 29

Table 51: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 30

Table 52: Vertebral Body Cage-Product Status 30

Table 53: Vertebral Body Cage-Product Description 30

Table 54: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 55: MIDIS Cage-Product Status 31

Table 56: MIDIS Cage-Product Description 31

Table 57: Glossary 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Camber Spine Technologies LLC, SPIRA Lateral; Camber Spine Technologies LLC, SPIRA Posterior Lumbar; Camber Spine Technologies LLC, SPIRA-L Open Architecture Lateral Cage; Corelink, LLC, Stand Alone Cervical Cage System; Corelink, LLC, Stand Alone Lumbar Cage System; DePuy Synthes Inc, Expandable Cage - Spine; EIT Emerging Implant Technologies GmbH, Fully Printed Lateral Expanding Cage; EIT Emerging Implant Technologies GmbH, Lateral Lumbar Cage; Inion Oy, Cervical Cage; Inion Oy, Lumbar Cage; KISCO International, Cambo; Maxigen Biotech Inc, MaxiCage; Medyssey Co Ltd, Unicorn Cs; Safe Orthopaedics SA, Cedar; Safe Orthopaedics SA, Elm; Safe Orthopaedics SA, Walnut; Spinal Balance Inc. , Interbody Cage; University of South Florida, Vertebral Body Cage; Vivonics, Inc., MIDIS Cage


Companies

Camber Spine Technologies LLC

Corelink, LLC

DePuy Synthes Inc

EIT Emerging Implant Technologies GmbH

Inion Oy

KISCO International

Maxigen Biotech Inc

Medyssey Co Ltd

Safe Orthopaedics SA

Spinal Balance Inc.

University of South Florida

Vivonics, Inc.